RISK ASSESSMENT FOR DISTANT METASTASIS IN DIFFERENTIATED THYROID CANCER USING MOLECULAR PROFILING
The authors of this case–control study compared the ThyroSeq genetic profiles of 62 patients with differentiated thyroid cancer with distant metastasis to a propensity-matched cohort without metastatic disease after over 5 years of follow-up. A TERT, TP53, or PIK3CA mutation was found in two-thirds of patients in the cohort with distant metastatic disease. The high-risk […]
